Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

Rectal Neoplasms 2Neoplasms 2Head and Neck Neoplasms 2Glioma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Wilms Tumor 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sinonasal Squamous Cell Carcinoma 1Radiation Injuries 1Prostatic Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Osteosarcoma 1Oropharyngeal Neoplasms 1Melanoma 1Lymphatic Metastasis 1Lung Neoplasms 1Low Anterior Resection Syndrome 1Liposarcoma 1Leiomyosarcoma 1Hepatic Veno-Occlusive Disease 1Glioblastoma 1Germinoma 1Fatigue 1Eyelid Squamous Cell Carcinoma 1

Interventions

pembrolizumab 17Bevacizumab 12Standard of Care 10Cyclophosphamide 9Carboplatin 9Doxorubicin 7Cetuximab 7Nivolumab 6Exercise 6olaparib 5atezolizumab 5Rituximab 5Radiotherapy 5Pemetrexed 5Fluorouracil 5Cisplatin 5durvalumab 4dostarlimab 4abemaciclib 4Temozolomide 4Prednisone 4Paclitaxel 4Leucovorin 4Blood Specimen Collection 4venetoclax 3temsirolimus 3talazoparib 3pertuzumab 3obinutuzumab 3ibrutinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Surgical Procedures, Operative × 30 days × Clear all
NCT05427136 2026-05-08

SWISS-Pearl

University Children's Hospital Basel

Recruiting
140 enrolled
Tumor-Agnostic

Neoplasms

NCT07000253 2026-05-07

OMEC-5

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2/3 Recruiting
290 enrolled
Gastrointestinal

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡